The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size for Minimally Invasive Glaucoma Surgery (MIGS) devices has experienced rapid growth recently. It is projected to increase from $0.7 billion in 2024 to $0.9 billion in 2025, with a compound annual growth rate (CAGR) of 28.3%.
The Minimally Invasive Glaucoma Surgery (MIGS) Devices market is projected to reach $2.42 billion by 2029, with a compound annual growth rate (CAGR) of 28.1%.
Download Your Free Sample of the 2025 Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Report and Uncover Key Trends Now!The drivers in the minimally invasive glaucoma surgery (migs) devices market are:
• Heightened awareness for preventing blindness
• Enhanced investment in healthcare infrastructure
• Increased patient knowledge of advanced corrective vision treatments
• Growth in government initiatives.
The minimally invasive glaucoma surgery (MIGS) devices market covered in this report is segmented –
1) By Product: Valves, Glaucoma Drainage Implant, Glaucoma Tube Shunts, Stents, Other Products
2) By Surgery: Glaucoma In Conjunction With Cataract, Stand Alone Glaucoma
3) By Target: Trabecular Meshwork, Suprachoroidal Space, Other Targets
4) By Distribution Channel: Direct Tender, Retail Sales
5) By End User: Ophthalmology Clinics, Ambulatory Surgery Centers (ASCS), Other End Users
The trends in the minimally invasive glaucoma surgery (migs) devices market are:
• Adoption of MIGS devices is gaining momentum as a significant emerging trend.
• Technological advancements are playing a crucial role in shaping the future of the MIGS devices market.
• Innovative developments in minimally invasive glaucoma surgery devices are becoming increasingly prevalent.
• A significant trend is the development of advanced implantable devices leveraged by advances in ophthalmic technology.
The major players in the minimally invasive glaucoma surgery (migs) devices market are:
• AbbVie Inc.
North America was the largest region in the minimally invasive glaucoma surgery (MIGS) devices market in 2024